Life sciences organizations have more data than ever to understand their markets. Claims reveal diagnoses and treatments. Prescription data shows utilization. Digital engagement indicates what healthcare professionals read or click.
But long before any of those signals appear, something important has already happened.
A clinician has started thinking about the patient in front of them.
IMO Health is introducing IMO Clinician Activity Signals, giving life sciences organizations an earlier view into changing clinician activity, weeks or months before those shifts become visible in traditional downstream data. The signal comes from the language physicians use every day and is grounded in IMO Health’s deep clinical terminology expertise and extensive presence across the U.S. healthcare ecosystem.
By applying precision clinical terminology expertise to aggregated clinician interactions, IMO Clinician Activity Signals reveals what is gaining attention across diseases, treatments, symptoms, and other clinically relevant concepts.
The result is a new way to understand what’s happening in the market right now – and where to act next.
Traditional data tells you what happened after the fact
Most healthcare data becomes available only after a clinical event has occurred. A diagnosis is coded. A prescription is written. A procedure is performed. A claim is submitted. Digital intent can provide an earlier view, but what a healthcare professional (HCP) reads or clicks does not necessarily reflect what clinicians are seeing in clinical practice.
IMO Clinician Activity Signals offers a different perspective.
By tracking changes in clinician activity over time and across geographies, and using the terminology physicians rely on to capture what they see, life sciences teams gain visibility into emerging disease and treatment trends, markets gaining momentum, and shifts in clinical interest.
That’s where the value changes.
Instead of waiting months to understand what happened, teams can start seeing movement sooner.
A brand team can evaluate activity changes following a launch or campaign. Medical affairs can assess shifts before, during, and after a congress, publication, guideline update, or educational initiative. Commercial leaders can identify emerging geographic opportunities and help inform field-force prioritization. HEOR teams can spot signals worth investigating further through RWD.
The connection becomes clearer: investment drives signal, signal drives action, and action drives outcomes.
“Life sciences teams have become exceptionally good at analyzing what has already happened,” said Matt McKinley, Executive Vice President and General Manager of Life Sciences at IMO Health. “IMO Clinician Activity Signals gives them an earlier vantage point into what may be changing in near-real time.
That means teams can identify opportunities sooner, understand whether their strategies are gaining traction, and make more informed decisions about where to act next.”
Moving beyond hindsight starts with seeing earlier
For more than 30 years, IMO Health has helped capture and preserve clinical intent as clinicians navigate care. IMO Clinician Activity Signals builds on that foundation by turning clinician activity into intelligence life sciences organizations can use.
It doesn’t replace claims, prescriptions, or real-world data. It helps teams understand where to look, what to investigate, and when to act.
Because when markets move quickly, knowing what happened matters. Seeing where they’re moving next matters more. Discover what clinicians are signaling.
